AGREEMENT Between NEW YORK UNIVERSITY and COLLATERAL THERAPEUTICS, INC.Research & License Agreement • December 22nd, 2005 • Aries Ventures Inc • Biological products, (no disgnostic substances)
KILROY CENTRE DEL MAR OFFICE LEASEOffice Lease • December 22nd, 2005 • Aries Ventures Inc • Biological products, (no disgnostic substances) • California
Exclusive License Agreement between The Regents of the University of California and Collateral Therapeutics. for Angiogenesis Gene TherapyExclusive License Agreement • December 22nd, 2005 • Aries Ventures Inc • Biological products, (no disgnostic substances) • California
This license agreement (“Agreement”) is effective this 27th day of September, 1995, by and between The Regents of the University of California (“The Regents”), a California corporation, having its statewide administrative offices at 300 Lakeside Drive, 22nd Floor, Oakland, California 94612-3550 and Collateral Therapeutics (“Licensee”), a California corporation, having a principal place of business at 9360 Towne Centre Drive, San Diego, California 92121.
YALE EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 22nd, 2005 • Aries Ventures Inc • Biological products, (no disgnostic substances) • Connecticut
THIS AGREEMENT by and between YALE UNIVERSITY, a corporation organized and existing under and by virtue of a charter granted by the general assembly of the Colony and State of Connecticut and located in New Haven, Connecticut (“YALE”), and SCHERING AKTIENGESELLSCHAFT with Offices in Müllerstrasse 178, D-13353, Berlin, Germany (“LICENSEE”) shall be effective the date of final execution below (“Effective Date”). Each of LICENSEE on one hand and YALE on the other hand, is referred to a “Party” and collectively as the “Parties.”
